India to Uzbekistan: Leflunomide Export Trade Route
India has recorded 7 verified shipments of Leflunomide exported to Uzbekistan, representing a combined trade value of $375.8K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $53.7K USD. The leading Indian exporter is KUSUM HEALTHCARE PRIVATE LIMITED, which accounts for 66% of total export value with 4 shipments worth $247.9K USD. On the buying side, FE BARAKA DORI FARM LLC is the largest importer in Uzbekistan with $169.8K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Uzbekistan Leflunomide corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $375.8K USD. The route is dominated by KUSUM HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 66% of all export value, reflecting the consolidated nature of India's leflunomide manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $53.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with leflunomide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 24.6%, placing it at rank #3 among India's top leflunomide export destinations globally.
On the import side, key buyers of Indian leflunomide in Uzbekistan include FE BARAKA DORI FARM LLC, FE BARAKA DORI FARM, LLC , FE BARAKA DORI FARM, LLC. and 2 others. FE BARAKA DORI FARM LLC is the single largest importer with 2 shipments valued at $169.8K USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ2
- Primary modeSea freight
- Top portTUGLAKABAD ICD (INTKD6)
Market Position
- Global rank#3
- Annual growth+24.6%
- Demand growth+22.6%
- Regulatory ease83/100
Top 10 Indian Leflunomide Exporters to Uzbekistan
Showing top 10 of 2 Indian suppliers exporting Leflunomide to Uzbekistan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | KUSUM HEALTHCARE PRIVATE LIMITED Avg $62.0K per shipment | 4 | $247.9K | 66.0% |
| 2 | KUSUM HEALTHCARE PRIVATE LIMITED Avg $42.6K per shipment | 3 | $127.9K | 34.0% |
This table shows the top 10 of 2 Indian companies exporting leflunomide to Uzbekistan, ranked by total trade value. The listed exporters are: KUSUM HEALTHCARE PRIVATE LIMITED, KUSUM HEALTHCARE PRIVATE LIMITED . KUSUM HEALTHCARE PRIVATE LIMITED is the dominant supplier with 4 shipments worth $247.9K USD, giving it a 66% market share.
Top 10 Leflunomide Importers in Uzbekistan
Showing top 10 of 5 known buyers in Uzbekistan receiving Leflunomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian leflunomide in Uzbekistan include FE BARAKA DORI FARM LLC, FE BARAKA DORI FARM, LLC , FE BARAKA DORI FARM, LLC., FE BARAKA DORI FARM, LLC. , FE BARAKA DORI FARM, LLC. The largest importer is FE BARAKA DORI FARM LLC, accounting for $169.8K USD across 2 shipments — representing 45% of all leflunomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FE BARAKA DORI FARM LLC | 2 | $169.8K | 45.2% |
| 2 | FE BARAKA DORI FARM, LLC | 2 | $100.8K | 26.8% |
| 3 | FE BARAKA DORI FARM, LLC. | 1 | $59.6K | 15.9% |
| 4 | FE BARAKA DORI FARM, LLC. | 1 | $27.1K | 7.2% |
| 5 | FE BARAKA DORI FARM, LLC | 1 | $18.5K | 4.9% |
Top 10 Leflunomide Formulations Imported by Uzbekistan
Showing top 10 of 6 product formulations shipped on the India to Uzbekistan Leflunomide route, ranked by trade value
Uzbekistan imports a wide range of leflunomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LEFNO-20 TABLETS 3X10S LEFLUNOMIDE 20MG B.NO.1001832 DOM- 04.2023 DOE-03.2026/B.NO.1001833 DOM-05.2023 DOE-04.2026 — accounts for $114.0K USD across 1 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LEFNO-20 TABLETS 3X10S LEFLUNOMIDE 20MG B.NO.1001832 DOM- 04.2023 DOE-03.2026/B.NO.1001833 DOM-05.2023 DOE-04.2026 | 1 | $114.0K | 30.3% |
| 2 | LEFNO-20 TABLETS 3X10S(LEFLUNOMIDE 20MG | 2 | $100.8K | 26.8% |
| 3 | LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20MG TABLETS) BT NO. 1002327 DOM-09.2023 DOE-08.2026 | 1 | $59.6K | 15.9% |
| 4 | LEFNO-20 TABLETS 3X10S LEFLUNOMIDE 20M | 1 | $55.8K | 14.8% |
| 5 | LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20M | 1 | $27.1K | 7.2% |
| 6 | LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20MG TABLETS) BATCH NO. 1005782 DOM -01.2025 DOE- 12.2027 | 1 | $18.5K | 4.9% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
TUGLAKABAD ICD (INTKD6) handles the highest volume with 2 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's leflunomide exports to Uzbekistan are driven primarily by a handful of large-scale manufacturers. KUSUM HEALTHCARE PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Uzbekistan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — KUSUM HEALTHCARE PRIVATE LIMITED, KUSUM HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $53.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lefno-20 tablets 3x10s(leflunomide 20mg and lefno-20 tablets 3x10s (leflunomide 20mg tablets) bt no. 1002327 dom-09.2023 doe-08.2026, suggesting that buyers in Uzbekistan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, FE BARAKA DORI FARM LLC is the largest importer with 2 shipments worth $169.8K USD — representing 45% of all leflunomide imports from India on this route.
Route Statistics
- Trade Volume
- $375.8K
- Avg. Shipment
- $53.7K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~29 days
- Annual Growth
- +24.6%
Related Analysis
Other Leflunomide Routes
Unlock the Full India to Uzbekistan Leflunomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 7 shipments on this route.
Frequently Asked Questions — India to Uzbekistan Leflunomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Leflunomide to Uzbekistan?
The leading Indian exporters of Leflunomide to Uzbekistan are KUSUM HEALTHCARE PRIVATE LIMITED, KUSUM HEALTHCARE PRIVATE LIMITED . KUSUM HEALTHCARE PRIVATE LIMITED holds the largest market share at approximately 66% of total trade value on this route.
Q What is the total value of Leflunomide exports from India to Uzbekistan?
India exports Leflunomide to Uzbekistan worth approximately $375.8K USD across 7 recorded shipments. The average value per shipment is $53.7K USD.
Q Which ports does India use to ship Leflunomide to Uzbekistan?
The most active port of origin is TUGLAKABAD ICD (INTKD6) with 2 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Uzbekistan for Leflunomide?
The average transit time for Leflunomide shipments from India to Uzbekistan is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Uzbekistan Leflunomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 24.6% with demand growth tracking at 22.6%. The route is ranked #3 among India's top Leflunomide export destinations globally.
Q How many suppliers are active on the India to Uzbekistan Leflunomide route?
There are currently 2 active Indian suppliers exporting Leflunomide to Uzbekistan. The market is moderately concentrated with KUSUM HEALTHCARE PRIVATE LIMITED accounting for 66% of total shipment value.
Q Who are the main importers of Leflunomide from India in Uzbekistan?
The leading importers of Indian Leflunomide in Uzbekistan include FE BARAKA DORI FARM LLC, FE BARAKA DORI FARM, LLC , FE BARAKA DORI FARM, LLC., FE BARAKA DORI FARM, LLC. , FE BARAKA DORI FARM, LLC. FE BARAKA DORI FARM LLC is the largest buyer with 2 shipments worth $169.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Uzbekistan export trade corridor identified from Indian Customs (DGFT) records for Leflunomide.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in Uzbekistan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 7 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists